BML Inc.
Financial Results Presentation for
the First Half of Fiscal 2021
November 11, 2021
Kensuke Kondo,
President and
Representative Director
Overview of the First Half of Fiscal 2021
2
First-Half Earnings History in 10 Years
Increase in tests related to COVID-19
(Millions of yen)
FY2021
1H
3
Year-on-Year Comparison
(Millions of yen)
FY2020 | FY2021 | YoY | Change | |
1H | 1H | |||
Net sales | 59,828 | 95,700 | 35,871 | 60.0% |
Testing business | 57,023 | 92,729 | 35,705 | 62.6% |
Clinical testing business | 55,226 | 90,695 | 35,469 | 64.2% |
Other testing business | 1,796 | 2,033 | 236 | 13.2% |
Medical informatics | 2,100 | 2,231 | 131 | 6.3% |
business | ||||
Other businesses | 705 | 739 | 34 | 4.9% |
Operating income | 4,973 | 27,525 | 22,552 | 453.4% |
Ordinary income | 5,275 | 28,433 | 23,158 | 439.0% |
Profit attributable to owners of | 3,514 | 18,761 | 15,246 | 433.8% |
parent | ||||
4
Breakdown of Changes in Sales by Business Segment
Net sales up ¥35,871m (60.0%) YoY
(Millions of yen)
+236 | +167 |
Food hygiene | Medical |
business, etc. | informatics |
business, | |
+35,469 | other businesses |
Clinical testing | |
business |
5
This is an excerpt of the original content. To continue reading it, access the original document here.